Lineage Cell Therapeutics Inc Asset Turnover Ratio (LCTX), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lineage Cell Therapeutics Inc   (NYSE: LCTX)
 

Lineage Cell Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Lineage Cell Therapeutics Inc asset turnover ratio, the ability of Lineage Cell Therapeutics Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.15 in the first quarter (Mar 31 2026), a new company high.

Within sector 39 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2538, from total ranking in the fourth quarter 2025 at 2696.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LCTX Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -1.99 % -0.56 % -7.2 % -11.68 % 3.01 %
Y / Y Revenue Change 14.85 % 130.4 % -2.59 % 96.38 % 4.02 %
Asset Turnover Ratio (TTM) 0.15 0.14 0.11 0.11 0.09
LCTX's Total Ranking # 2538 # 2696 # 349 # 385 # 379
Seq. Asset Change -2.71 % 25.6 % -1.28 % -18.75 % -1.29 %
Seq. Revenue Change -73.9 % 79.52 % 33.13 % 84.09 % -47.63 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 40
Healthcare Sector # 417
Overall Market # 2538

Asset Turnover Ratio Statistics
High Average Low
0.15 0.07 0.01
(Mar 31 2026)   (Mar 31 2018)




LCTX Company Profile • Back to LCTX Efficiency Comparisons • Compare LCTX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Sotera Health Company  0.37 $ 1,188.171  Millions$ 3,225.495  Millions
Xilio Therapeutics Inc   0.37 $ 53.484  Millions$ 146.420  Millions
Zimmer Biomet Holdings Inc   0.36 $ 8,409.100  Millions$ 23,041.600  Millions
Meiragtx Holdings Plc  0.36 $ 79.758  Millions$ 219.318  Millions
Elanco Animal Health Incorporated  0.36 $ 4,893.000  Millions$ 13,468.250  Millions
Orchestra Biomed Holdings Inc   0.36 $ 32.724  Millions$ 90.787  Millions
Precision Biosciences Inc  0.36 $ 45.073  Millions$ 125.186  Millions
Aquestive Therapeutics Inc   0.36 $ 50.271  Millions$ 139.702  Millions
Quanterix Corporation  0.36 $ 144.110  Millions$ 401.297  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,139.000  Millions$ 40,193.750  Millions
Geron Corporation  0.35 $ 195.857  Millions$ 556.810  Millions
Picard Medical Inc   0.35 $ 5.160  Millions$ 14.748  Millions
Assembly Biosciences Inc   0.35 $ 71.097  Millions$ 203.469  Millions
Invo Fertility Inc   0.35 $ 7.219  Millions$ 20.757  Millions
Butterfly Network Inc   0.35 $ 102.639  Millions$ 296.434  Millions
Biogen Inc   0.34 $ 9,937.400  Millions$ 29,115.075  Millions
The Cooper Companies Inc   0.34 $ 4,230.400  Millions$ 12,419.500  Millions
Beta Bionics Inc   0.34 $ 110.003  Millions$ 323.294  Millions
Polomar Health Services, Inc.  0.34 $ 1.649  Millions$ 4.902  Millions
Elutia Inc   0.33 $ 14.984  Millions$ 45.204  Millions
Amarin Corp Plcuk  0.33 $ 216.761  Millions$ 661.620  Millions
Krystal Biotech Inc   0.33 $ 417.304  Millions$ 1,277.312  Millions
Ionis Pharmaceuticals Inc   0.32 $ 1,033.082  Millions$ 3,192.972  Millions
Insmed Inc  0.32 $ 737.256  Millions$ 2,295.254  Millions
Sonida Senior Living Inc   0.32 $ 411.850  Millions$ 1,294.165  Millions
Plus Therapeutics Inc   0.32 $ 5.182  Millions$ 16.315  Millions
Volitionrx Limited  0.32 $ 2.466  Millions$ 7.773  Millions
Lexicon Pharmaceuticals Inc   0.31 $ 69.643  Millions$ 221.329  Millions
Prestige Consumer Healthcare Inc   0.31 $ 1,088.578  Millions$ 3,465.740  Millions
Iovance Biotherapeutics inc   0.31 $ 285.608  Millions$ 912.805  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.